Operaciones Morphic Holding, Inc. - MORF CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | - | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Morphic Holding Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Cierre previo* | N/A |
Abrir* | N/A |
Cambio de 1 año* | N/A |
Rango del día* | N/A |
Rango de 52 semanas | 19.23-60.23 |
Volumen medio (10 días) | 441.89K |
Volumen medio (3 meses) | 12.40M |
Capitalización de mercado | 2.57B |
Ratio P/E | -100.00K |
Acciones en circulación | 44.97M |
Ingresos | 68.95M |
EPS | -1.63 |
Dividendo (Rendimiento %) | N/A |
Beta | 1.15 |
Próxima fecha de resultados | Aug 1, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|
Morphic Holding, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
Tuesday, August 1, 2023 | ||
Hora (UTC) (UTC) 12:30 | País US
| Evento Q2 2023 Morphic Holding Inc Earnings Release Q2 2023 Morphic Holding Inc Earnings ReleaseForecast -Previous - |
Tuesday, October 31, 2023 | ||
Hora (UTC) (UTC) 12:30 | País US
| Evento Q3 2023 Morphic Holding Inc Earnings Release Q3 2023 Morphic Holding Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 70.808 | 19.794 | 44.945 | 16.977 | 3.358 |
Ingresos | 70.808 | 19.794 | 44.945 | 16.977 | 3.358 |
Gastos totales de explotación | 134.204 | 115.6 | 92.125 | 63.965 | 27.986 |
Gastos de venta/general/administración Gastos, total | 32.142 | 27.811 | 18.495 | 10.233 | 5.355 |
Investigación y desarrollo | 102.062 | 87.789 | 73.63 | 53.732 | 22.631 |
Ingresos de explotación | -63.396 | -95.806 | -47.18 | -46.988 | -24.628 |
Ingresos por intereses (gastos), netos No operativos | 4.567 | 0.272 | 1.63 | 4.666 | 0.871 |
Otros, netos | -0.145 | -0.008 | -0.019 | -0.094 | -0.074 |
Ingresos netos antes de impuestos | -58.974 | -95.542 | -45.569 | -42.416 | -23.831 |
Ingresos netos después de impuestos | -59.041 | -95.542 | -44.999 | -43.328 | -23.831 |
Beneficio neto antes de partidas extra. Elementos | -59.041 | -95.542 | -44.999 | -43.328 | -23.831 |
Ingresos netos | -59.041 | -95.542 | -44.999 | -43.328 | -23.831 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -59.041 | -95.542 | -44.999 | -43.328 | -23.831 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -59.041 | -95.542 | -44.999 | -43.328 | -23.831 |
Beneficio neto diluido | -59.041 | -95.542 | -44.999 | -43.328 | -23.831 |
Promedio ponderado de acciones diluidas | 38.1125 | 35.798 | 30.5949 | 30.1103 | 29.5964 |
BPA diluido sin partidas extraordinarias | -1.54912 | -2.66892 | -1.4708 | -1.43898 | -0.8052 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
BPA normalizado diluido | -1.54912 | -2.66892 | -1.4708 | -1.43898 | -0.80615 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Ingresos totales | 0.521 | 6.135 | 2.055 | 60.236 | 2.382 |
Ingresos | 0.521 | 6.135 | 2.055 | 60.236 | 2.382 |
Gastos totales de explotación | 39.726 | 32.716 | 33.548 | 33.886 | 34.054 |
Gastos de venta/general/administración Gastos, total | 9.277 | 8.014 | 8.303 | 8.234 | 7.591 |
Investigación y desarrollo | 30.449 | 24.702 | 25.245 | 25.652 | 26.463 |
Ingresos de explotación | -39.205 | -26.581 | -31.493 | 26.35 | -31.672 |
Ingresos por intereses (gastos), netos No operativos | 3.1 | 2.241 | 1.657 | 0.482 | 0.187 |
Otros, netos | 0.002 | -0.001 | -0.156 | 0.011 | 0.001 |
Ingresos netos antes de impuestos | -36.103 | -24.341 | -29.992 | 26.843 | -31.484 |
Ingresos netos después de impuestos | -36.135 | -24.377 | -30.021 | 26.841 | -31.484 |
Beneficio neto antes de partidas extra. Elementos | -36.135 | -24.377 | -30.021 | 26.841 | -31.484 |
Ingresos netos | -36.135 | -24.377 | -30.021 | 26.841 | -31.484 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -36.135 | -24.377 | -30.021 | 26.841 | -31.484 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -36.135 | -24.377 | -30.021 | 26.841 | -31.484 |
Beneficio neto diluido | -36.135 | -24.377 | -30.021 | 26.841 | -31.484 |
Promedio ponderado de acciones diluidas | 40.1124 | 38.5662 | 38.4909 | 39.5546 | 37.1334 |
BPA diluido sin partidas extraordinarias | -0.90084 | -0.63208 | -0.77995 | 0.67858 | -0.84786 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.90084 | -0.63208 | -0.77995 | 0.67858 | -0.84786 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Activo Corriente | 362.182 | 418.334 | 239.435 | 243.573 | 187.123 |
Efectivo e inversiones a corto plazo | 348.248 | 408.135 | 227.989 | 237.016 | 185.901 |
Efectivo y Equivalentes | 59.272 | 171.434 | 101.772 | 101.559 | 185.901 |
Inversiones a corto plazo | 288.976 | 236.701 | 126.217 | 135.457 | 0 |
Total deudores, neto | 0.455 | 2.307 | 7.314 | 3.467 | 0 |
Accounts Receivable - Trade, Net | 0.455 | 2.307 | 7.314 | 3.467 | 0 |
Prepaid Expenses | 13.479 | 7.892 | 3.857 | 3.09 | 1.222 |
Total Assets | 368.589 | 426.29 | 242.382 | 247.435 | 189.305 |
Property/Plant/Equipment, Total - Net | 5.633 | 7.389 | 2.606 | 3.446 | 1.843 |
Property/Plant/Equipment, Total - Gross | 10.815 | 11.566 | 5.759 | 3.053 | |
Accumulated Depreciation, Total | -5.182 | -4.177 | -3.153 | -1.21 | |
Other Long Term Assets, Total | 0.774 | 0.567 | 0.341 | 0.416 | 0.339 |
Total Current Liabilities | 17.126 | 38.264 | 39.438 | 35.35 | 34.903 |
Accounts Payable | 3.475 | 4.798 | 3.845 | 5.167 | 1.745 |
Accrued Expenses | 13.181 | 12.838 | 10.16 | 6.639 | 3.239 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | ||||
Other Current Liabilities, Total | 0.47 | 20.628 | 25.433 | 23.544 | 29.919 |
Total Liabilities | 19.47 | 89.591 | 97.185 | 106.517 | 102.048 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | ||||
Other Liabilities, Total | 2.344 | 51.327 | 57.747 | 71.167 | 67.145 |
Total Equity | 349.119 | 336.699 | 145.197 | 140.918 | 87.257 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Preferred Stock - Non Redeemable, Net | 139.809 | ||||
Common Stock | 0.004 | 0.004 | 0.003 | 0.003 | 0 |
Additional Paid-In Capital | 649.549 | 575.231 | 287.727 | 238.384 | 1.633 |
Retained Earnings (Accumulated Deficit) | -297.095 | -238.054 | -142.512 | -97.513 | -54.185 |
Unrealized Gain (Loss) | -3.339 | -0.482 | -0.021 | 0.044 | 0 |
Total Liabilities & Shareholders’ Equity | 368.589 | 426.29 | 242.382 | 247.435 | 189.305 |
Total Common Shares Outstanding | 38.5847 | 37.0854 | 32.0377 | 30.1103 | 29.5964 |
Other Current Assets, Total | 0.275 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 435.745 | 362.182 | 382.41 | 406.619 | 389.494 |
Efectivo e inversiones a corto plazo | 421.279 | 348.248 | 371.76 | 397.56 | 380.652 |
Efectivo y Equivalentes | 41.901 | 59.272 | 84.961 | 141.183 | 119.842 |
Inversiones a corto plazo | 379.378 | 288.976 | 286.799 | 256.377 | 260.81 |
Total deudores, neto | 0.506 | 0.455 | 0.662 | 1.036 | 2.039 |
Accounts Receivable - Trade, Net | 0.506 | 0.455 | 0.662 | 1.036 | 2.039 |
Prepaid Expenses | 13.96 | 13.479 | 9.988 | 8.023 | 6.803 |
Total Assets | 441.947 | 368.589 | 389.181 | 413.875 | 397.073 |
Property/Plant/Equipment, Total - Net | 5.417 | 5.633 | 6.015 | 6.542 | 6.858 |
Other Long Term Assets, Total | 0.785 | 0.774 | 0.756 | 0.714 | 0.721 |
Total Current Liabilities | 13.481 | 17.126 | 18.586 | 19.684 | 43.792 |
Accounts Payable | 5.482 | 3.475 | 4.367 | 3.885 | 3.496 |
Accrued Expenses | 7.999 | 13.181 | 10.874 | 11.347 | 9.988 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 0.47 | 3.345 | 4.452 | 30.308 |
Total Liabilities | 15.432 | 19.47 | 24.12 | 25.885 | 83.705 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 1.951 | 2.344 | 5.534 | 6.201 | 39.913 |
Total Equity | 426.515 | 349.119 | 365.061 | 387.99 | 313.368 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
Additional Paid-In Capital | 761.429 | 649.549 | 641.872 | 633.1 | 584.694 |
Retained Earnings (Accumulated Deficit) | -333.23 | -297.095 | -272.718 | -242.697 | -269.538 |
Unrealized Gain (Loss) | -1.688 | -3.339 | -4.097 | -2.417 | -1.792 |
Total Liabilities & Shareholders’ Equity | 441.947 | 368.589 | 389.181 | 413.875 | 397.073 |
Total Common Shares Outstanding | 39.6415 | 38.5847 | 38.5324 | 38.4486 | 37.2505 |
Other Current Assets, Total | |||||
Property/Plant/Equipment, Total - Gross | |||||
Accumulated Depreciation, Total | |||||
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -59.041 | -95.542 | -44.999 | -43.328 | -23.831 |
Efectivo de actividades de explotación | -100.977 | -83.461 | -45.99 | -41.651 | 76.337 |
Efectivo de actividades de explotación | 1.005 | 1.03 | 1.126 | 0.821 | 0.539 |
Partidas no monetarias | 30.002 | 22.403 | 11.503 | 2.043 | 1.069 |
Intereses pagados en efectivo | 0 | 0.068 | |||
Cambios en el capital circulante | -72.943 | -11.352 | -13.62 | -1.187 | 98.56 |
Efectivo de actividades de inversión | -56.451 | -113.18 | 8.181 | -135.986 | -0.656 |
Gastos de capital | -0.365 | -1.02 | -0.544 | -2.158 | -0.659 |
Otras partidas de flujo de caja de inversión, total | -56.086 | -112.16 | 8.725 | -133.828 | 0.003 |
Efectivo procedente de actividades de financiación | 45.266 | 266.313 | 38.297 | 93.295 | 89.47 |
Emisión (retiro) de acciones, neto | 6.056 | 240.613 | 4.644 | 93.295 | 90.122 |
Emisión (amortización) de deuda, neta | 0 | -0.652 | |||
Variación neta de la tesorería | -112.162 | 69.672 | 0.488 | -84.342 | 165.151 |
Cash Taxes Paid | 0.05 | 0.17 | 0.48 | 0.55 | |
Elementos de flujo de caja de financiación | 39.21 | 25.7 | 33.653 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -36.135 | -59.041 | -34.664 | -4.643 | -31.484 |
Cash From Operating Activities | -31.454 | -100.977 | -75.859 | -50.965 | -28.148 |
Cash From Operating Activities | 0.257 | 1.005 | 0.762 | 0.511 | 0.263 |
Non-Cash Items | 8.676 | 30.002 | 23.216 | 15.521 | 7.372 |
Cash Taxes Paid | |||||
Changes in Working Capital | -4.252 | -72.943 | -65.173 | -62.354 | -4.299 |
Cash From Investing Activities | -88.401 | -56.451 | -55.305 | -22.796 | -26.074 |
Capital Expenditures | -0.55 | -0.365 | -0.301 | -0.052 | -0.048 |
Other Investing Cash Flow Items, Total | -87.851 | -56.086 | -55.004 | -22.744 | -26.026 |
Cash From Financing Activities | 102.484 | 45.266 | 44.691 | 43.51 | 2.63 |
Financing Cash Flow Items | 39.21 | 39.25 | 39.281 | 0 | |
Issuance (Retirement) of Stock, Net | 102.484 | 6.056 | 5.441 | 4.229 | 2.63 |
Net Change in Cash | -17.371 | -112.162 | -86.473 | -30.251 | -51.592 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Springer Timothy A | Individual Investor | 14.6378 | 6583327 | 806223 | 2023-04-01 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 13.1851 | 5929965 | 147242 | 2023-03-31 | LOW |
EcoR1 Capital, LLC | Hedge Fund | 8.5596 | 3849666 | 2700 | 2023-04-01 | LOW |
Polaris Venture Partners | Venture Capital | 4.6485 | 2090651 | 0 | 2023-04-01 | LOW |
Invus Public Equities Advisors, LLC | Investment Advisor | 4.0333 | 1813949 | -336051 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.9822 | 1790966 | -28405 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.7489 | 1686077 | 18692 | 2023-03-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 3.2863 | 1478017 | 359389 | 2023-03-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.4523 | 1102924 | -306589 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.3886 | 1074285 | -463504 | 2023-03-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 1.9649 | 883699 | 124853 | 2023-03-31 | MED |
Federated Hermes Global Investment Management Corp. | Investment Advisor/Hedge Fund | 1.4023 | 630700 | 0 | 2023-03-31 | LOW |
Tipirneni (Praveen P) | Individual Investor | 1.3972 | 628410 | 0 | 2023-05-03 | |
Holocene Advisors, LP | Hedge Fund | 1.3764 | 619032 | -246598 | 2023-03-31 | HIGH |
Omega Fund Management, LLC | Investment Advisor | 1.329 | 597723 | 0 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.2104 | 544393 | 17158 | 2023-03-31 | LOW |
Woodline Partners LP | Hedge Fund | 0.7782 | 350000 | -288552 | 2023-03-31 | HIGH |
Cormorant Asset Management, LP | Hedge Fund | 0.7226 | 325000 | 325000 | 2023-03-31 | LOW |
Nuveen LLC | Pension Fund | 0.7185 | 323161 | -14675 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.6825 | 306968 | 55726 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Morphic Holding, Inc. Company profile
Sobre Morphic Holding Inc
Morphic Holding, Inc. es una empresa biofarmacéutica. La empresa se dedica a descubrir y desarrollar una línea de productos terapéuticos orales a base de pequeñas moléculas para las integrinas. Las integrinas son una clase de objetivo con múltiples fármacos inyectables aprobados para el tratamiento de enfermedades crónicas graves, incluyendo enfermedades autoinmunes, cardiovasculares y metabólicas, fibrosis y cáncer. La empresa está avanzando en su cartera de productos, incluido su principal candidato, MORF-057, un inhibidor de las integrinas Alfa 4 y Beta 7 que afecta a la inflamación, para el tratamiento de la enfermedad inflamatoria intestinal (EII). También ha desarrollado inhibidores orales de la integrina específica αvb6, como MORF-720 y MORF-627, para el tratamiento de enfermedades fibróticas, como la fibrosis pulmonar idiopática (FPI). La empresa utiliza su plataforma MInT para hacer avanzar una serie de programas preclínicos en diversas áreas terapéuticas.
El precio actual de la acción Morphic Holding, Inc. en tiempo real es 0 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: SPS Commerce, OpGen, Inc., Alphabet Inc, Northfield Bancorp, Check Point Software Technologies Ltd. y Capitol Federal. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Biotechnology & Medical Research (NEC) |
35 Gatehouse Dr # A2
WALTHAM
MASSACHUSETTS 02451-1215
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com